Shattuck Labs Financials
STTK Stock | USD 1.01 0.01 1.00% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 7.66 | 12.505 |
|
|
The essential information of the day-to-day investment outlook for Shattuck Labs includes many different criteria found on its balance sheet. An individual investor should monitor Shattuck Labs' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Shattuck Labs.
Net Income |
|
Shattuck | Select Account or Indicator |
Understanding current and past Shattuck Labs Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Shattuck Labs' financial statements are interrelated, with each one affecting the others. For example, an increase in Shattuck Labs' assets may result in an increase in income on the income statement.
Shattuck Labs Stock Summary
Shattuck Labs competes with C4 Therapeutics, Eliem Therapeutics, Prelude Therapeutics, Monte Rosa, and Foghorn Therapeutics. Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company was incorporated in 2016 and is headquartered in Austin, Texas. Shattuck Labs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 85 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US82024L1035 |
CUSIP | 82024L103 |
Location | Texas; U.S.A |
Business Address | 500 West 5th |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.shattucklabs.com |
Phone | 512 900 4690 |
Currency | USD - US Dollar |
Shattuck Labs Key Financial Ratios
Return On Equity | -0.68 | ||||
Operating Margin | (14.27) % | ||||
Price To Sales | 11.69 X | ||||
Revenue | 1.66 M | ||||
Gross Profit | (82.25 M) |
Shattuck Labs Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 45.0M | 349.0M | 298.6M | 205.3M | 159.6M | 206.4M | |
Other Current Liab | 425K | 7.4M | 14.6M | 17.1M | 9.1M | 8.9M | |
Net Tangible Assets | (34.5M) | 309.9M | 271.8M | 176.2M | 202.6M | 156.7M | |
Net Debt | (7.0M) | (157.9M) | (92.3M) | (43.2M) | (121.4M) | (115.4M) | |
Retained Earnings | (35.5M) | (72.1M) | (117.1M) | (219.0M) | (306.3M) | (291.0M) | |
Accounts Payable | 3.1M | 1.8M | 10.0M | 7.2M | 1.6M | 1.5M | |
Cash | 7.0M | 157.9M | 92.3M | 47.4M | 125.6M | 84.7M | |
Other Assets | 90K | 349K | 10.3M | 434K | 1.0 | 0.95 | |
Other Current Assets | 3.4M | 20.4M | 38.9M | 23.3M | 12.6M | 19.0M | |
Total Liab | 79.5M | 39.1M | 26.8M | 29.2M | 14.9M | 14.1M | |
Net Invested Capital | (34.5M) | 309.9M | 271.8M | 176.2M | 144.7M | 157.1M | |
Total Current Assets | 42.4M | 345.6M | 288.3M | 184.6M | 143.2M | 196.1M | |
Net Working Capital | 22.5M | 328.8M | 263.7M | 159.6M | 131.8M | 174.4M |
Shattuck Labs Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Net Interest Income | 1.2M | 549K | 625K | 1.6M | 4.7M | 4.9M | |
Interest Income | 1.2M | 549K | 625K | 1.6M | 4.7M | 4.9M | |
Total Revenue | 9.9M | 9.9M | 30.0M | 652K | 1.7M | 1.6M | |
Gross Profit | (19.1M) | 9.9M | 28.6M | 652K | (2.4M) | (2.3M) | |
Operating Income | (25.1M) | (36.9M) | (45.3M) | (103.3M) | (92.0M) | (87.4M) | |
Ebit | (25.1M) | (36.9M) | (45.3M) | (103.3M) | (91.7M) | (87.1M) | |
Research Development | 29.2M | 37.5M | 56.6M | 82.9M | 74.3M | 56.0M | |
Ebitda | (23.4M) | (36.3M) | (43.9M) | (100.3M) | (87.6M) | (83.2M) | |
Income Before Tax | (24.0M) | (36.6M) | (45.0M) | (101.9M) | (87.3M) | (82.9M) | |
Net Income | (23.9M) | (35.4M) | (44.3M) | (100.6M) | (87.3M) | (82.9M) | |
Income Tax Expense | (99K) | (1.2M) | (625K) | (1.4M) | 3.9M | 4.1M |
Shattuck Labs Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Investments | (3.1M) | (145.6M) | (2.5M) | 60.9M | 86.5M | 90.8M | |
Change In Cash | (24.6M) | 150.9M | (65.6M) | (44.9M) | 78.2M | 82.2M | |
Free Cash Flow | (21.4M) | (34.4M) | (65.0M) | (106.1M) | (81.6M) | (85.7M) | |
Depreciation | 537K | 618K | 1.4M | 3.1M | 4.0M | 4.2M | |
Other Non Cash Items | (41K) | 89K | 1.5M | 2.4M | (816K) | (775.2K) | |
Capital Expenditures | 470K | 727K | 7.9M | 11.6M | 407K | 386.7K | |
Net Income | (24.0M) | (36.6M) | (45.0M) | (101.9M) | (87.3M) | (82.9M) | |
End Period Cash Flow | 7.0M | 157.9M | 92.3M | 47.4M | 125.6M | 84.7M | |
Change To Netincome | 295K | 1.3M | 5.5M | 7.2M | 8.2M | 8.7M |
Shattuck Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shattuck Labs's current stock value. Our valuation model uses many indicators to compare Shattuck Labs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shattuck Labs competition to find correlations between indicators driving Shattuck Labs's intrinsic value. More Info.Shattuck Labs is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Shattuck Labs' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Shattuck Labs by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Shattuck Labs Systematic Risk
Shattuck Labs' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Shattuck Labs volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Shattuck Labs correlated with the market. If Beta is less than 0 Shattuck Labs generally moves in the opposite direction as compared to the market. If Shattuck Labs Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Shattuck Labs is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Shattuck Labs is generally in the same direction as the market. If Beta > 1 Shattuck Labs moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Shattuck Labs Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Shattuck Labs' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Shattuck Labs growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Shattuck Labs November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Shattuck Labs help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Shattuck Labs. We use our internally-developed statistical techniques to arrive at the intrinsic value of Shattuck Labs based on widely used predictive technical indicators. In general, we focus on analyzing Shattuck Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Shattuck Labs's daily price indicators and compare them against related drivers.
Information Ratio | (0.19) | |||
Maximum Drawdown | 51.03 | |||
Value At Risk | (9.82) | |||
Potential Upside | 6.78 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shattuck Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Shattuck Stock please use our How to buy in Shattuck Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shattuck Labs. If investors know Shattuck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shattuck Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Revenue Per Share 0.088 | Quarterly Revenue Growth 7.045 | Return On Assets (0.40) | Return On Equity (0.68) |
The market value of Shattuck Labs is measured differently than its book value, which is the value of Shattuck that is recorded on the company's balance sheet. Investors also form their own opinion of Shattuck Labs' value that differs from its market value or its book value, called intrinsic value, which is Shattuck Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shattuck Labs' market value can be influenced by many factors that don't directly affect Shattuck Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shattuck Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shattuck Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shattuck Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.